DOTTI, KATIA FIORELLA

DOTTI, KATIA FIORELLA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer : an Italian Trials of Medical Oncology phase II study 1-gen-2015 F. PietrantonioK. F. DottiC. Maggi + Article (author) -
Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer : a phase II study 1-gen-2014 F. PietrantonioF. ValvoK. F. DottiP. BiondaniA. Gevorgyan + Article (author) -
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens 1-ago-2014 F. de BraudA. GevorgyanDOTTI, KATIA FIORELLAF. Pietrantonio + Article (author) -
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer 1-giu-2016 F. PietrantonioF. de BraudC. MaggiK.F. DottiA. Pellegrinelli + Article (author) -
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT 1-gen-2014 F. PietrantonioK. F. DottiP. Biondani + Article (author) -
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 1-dic-2019 Fucà GMariani LGalli GDi Nicola MVernieri CDotti KPietrantonio Fde Braud F + Article (author) -